CNS PHARMACEUTICALS, INC. (CNSP) Social Stream
CNS PHARMACEUTICALS INC (CNSP) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering CNSP.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-03 | 2 | $10 | $10 | $10 | $1.15 | 769.57% |
| 2021-12-08 | 2 | $10 | $4 | $7 | $1.15 | 508.7% |
| 2022-04-08 | 3 | $10 | $2 | $6.333 | $1.15 | 450.7% |
| 2022-06-03 | 2 | $10 | $1 | $5.5 | $1.15 | 378.26% |
| NA | 1 | $NA | $NA | $NA | $1.15 | NA% |
The Trend in the Analyst Price Target
CNSP's average price target has moved down $2.33 over the prior 13 months.
500 - Internal server error
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|
CNSP Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 1 | 0 | 1 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
Over the past 48 weeks, CNSP's average broker recommendation rating improved by 1.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- CNS PHARMACEUTICALS INC's number of analysts covering the stock is greater than 40.84% of all US stocks.
- CNSP has a higher upside potential (average analyst target price relative to current price) than 752.75% of all US stocks.
- In the context of all US stocks, CNS PHARMACEUTICALS INC's average analyst price target is higher than 52.56% of them.
- In the context of stocks in the micro market cap category, CNS PHARMACEUTICALS INC's variance in analysts' estimates is lower than -533.36% of them.
Stocks similar to CNS PHARMACEUTICALS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are TRVI, HOTH, and TLSA.
View All Top Stocks by Price Target
Is CNSP a Buy, Hold or Sell? See the POWR Ratings now!